Minimally Invasive Surgical Therapy for BPH

PHASE3TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

June 30, 2006

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

Transurethral Microwave Thermotherapy (TUMT)

type of minimally invasive surgical therapy for BPH

DEVICE

Transurethral Needle Ablation (TUNA) Therapy

type of minimally invasive surgical therapy for BPH

DRUG

Finasteride and Alfuzosin

finasteride in a daily dose of 5 mg and alfuzosin in a daily dose of 10 mg

Trial Locations (7)

10032

Columbia University, New York

53226

Medical College of Wisconsin, Milwaukee

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

80010

University of Colorado Health Sciences Center, Denver

All Listed Sponsors
collaborator

Diagnostic Ultrasound

INDUSTRY

collaborator

Urologix

INDUSTRY

collaborator

Medtronic

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH